Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma

Published:2021-07 Issue: Volume:151 Page:106-114
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Carril-Ajuria Lucia^ORCID,Colomba Emeline,Cerbone Luigi^ORCID,Romero-Ferreiro Carmen^ORCID,Crouzet Laurence,Laguerre Brigitte,Thibault Constance,Vicier Cécile,de Velasco Guillermo,Fléchon Aude,Saldana Carolina,Benusiglio Patrick R.^ORCID,Bressac-de Paillerets Brigitte,Guillaud-Bataille Marine,Gaignard Pauline^ORCID,Scoazec Jean-Yves^ORCID,Richard Stéphane,Caron Olivier,Escudier Bernard,Albiges Laurence^ORCID

Funder

AstraZeneca

Janssen Pharmaceuticals

Sanofi

Pfizer

Novartis

Astellas Pharma US

Ipsen

Merck

Meso Scale Diagnostics

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Molecular pathways: fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer;Linehan;Clin Canc Res Off J Am Assoc Canc Res,2013

2. A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients;Lau;Am J Surg Pathol,2020

3. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers: MULLER et al;Muller;Clin Genet,2017

4. Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary renal cell cancer;Srinivasan;J Clin Oncol,2020

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional implications of fumarate-induced cysteine succination;Trends in Biochemical Sciences;2024-09

2. Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer;BMC Medical Genomics;2024-08-19

3. Fumarate hydratase-deficient renal cell carcinoma: A rare case report;Asian Journal of Surgery;2024-08

4. Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma;Frontiers in Pharmacology;2024-06-21

5. Prevalence and prognosis of hypoxia‐inducible factor‐2α (HIF‐2α) pathway gene mutations across advanced solid tumors;Cancer Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3